1. Home
  2. Recombinant Proteins and Antibody Research Tools
  3. SARS-CoV-2 Recombinant Proteins
  4. SARS-CoV-2 full-length Trimeric Spike Recombinant Antigen B.1.525 Mutation (UK/Nigerian Variant) (1 mg)

SARS-CoV-2 full-length Trimeric Spike Recombinant Antigen B.1.525 Mutation (UK/Nigerian Variant) (1 mg)

£3,000.00

1 mg

1 ml buffer solution with 0.001% LMNG provided separately FREE OF CHARGE
SKU: BSV-COV-PR-86

SARS-CoV-2 Spike Antigen B.1.525 (UK/Nigerian Variant)

All viruses undergo fast mutations and adept quickly to the countermeasures that the immune systems creates against them. SARS-CoV-2 of the COVID-19 pandemic is no exception here. Spike protein of the mutant strain B.1.525 is a full-length protein, which is active in its native trimeric form, that is stabilized in LMNG detergent.

Features

Product Name: SARS-CoV-2 full-length Trimeric Spike Recombinant Antigen (UK/Nigerian Variant)
PHE Reference: VUI-21FEB-03
UniProt Number: P0DTC2
Host: HEK293
Mutations that differ from SPIKE Protein: del 69-70, del 144, Q52R, E484K, Q667H, F888L
Further Modifications: Furin cleavage site “RRAR” mutated to “GSAG”; KV986P; V987P
Buffer Composition: 20 mM Hepes pH 7.5; 150 mM NaCl, 0.001% LMNG
Molecular Weight: 141 kDa

Menu